Crossmark

Murine RAW264.7 cells as cellular drug delivery carriers for tumor therapy: a good idea?

Crossref DOI link: https://doi.org/10.1007/s00280-018-3735-0

Published Online: 2018-11-30

Published Print: 2019-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Huangliang

Li, Jiaqi

Luo, Xiang

LI, Cong

Hu, Ling

Qiu, Qiujun

Ding, Junqiang

Song, Yanzhi

Deng, Yihui
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (No.81373334)

National Natural Science Foundation of China (No.81703456)

Science and technology department of Liaoning Province (201601140)
License Information

Text and Data Mining valid from 2018-11-30
More Information

Article History

Received: 1 August 2018

Accepted: 25 November 2018

First Online: 30 November 2018

Compliance with ethical standards

:

: All authors declare that they have no conflicts of interest.

: All procedures performed in studies involving animal experiments were in accordance with the ethical standards of the Animal Ethics Committee of Shenyang Pharmaceutical University. This article does not contain any studies with human participants performed by any of the authors.